Chad Rusthoven: “Overall survival was found to be superior with stereotactic radiosurgery versus hippocampal-avoidant whole-brain radiotherapy”. (Courtesy: © ASTRO/Luke Franke 2026)"> Chad Rusthoven: “Overall survival was found to be superior with stereotactic radiosurgery versus hippocampal-avoidant whole-brain radiotherapy”. (Courtesy: © ASTRO/Luke Franke 2026)

At this week’s ASTRO 2026 meeting in Boston, MA, researchers shared the results of clinical trials addressing important and longstanding questions in cancer care. In a dedicated news briefing highlighting noteworthy research studies, two speakers presented new evidence that could help inform how we deliver care to patients with brain metastases.

Brain metastases – cancerous cells that spread to the brain from another site in the body – are typically removed surgically or treated with radiotherapy.…